|
Oncogenes and Tumor Suppressors
Citations 221-230 of 795 total displayed.
|
Past content
(since May 2000):
|
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
- Robert Kralovics, Soon-Siong Teo, Sai Li, Alexandre Theocharides, Andreas S. Buser, Andre Tichelli, and Radek C. Skoda
Blood 2006; 108: 1377-1380.
[Abstract]
[Full text]
[PDF]
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation–related imatinib failure
- Elias Jabbour, Jorge Cortes, Hagop M. Kantarjian, Sergio Giralt, Dan Jones, Roy Jones, Francis Giles, Borje S. Andersson, Richard Champlin, and Marcos de Lima
Blood 2006; 108: 1421-1423.
[Abstract]
[Full text]
[PDF]
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
- Abhik Datta, Marcia Bellon, Uma Sinha-Datta, Ali Bazarbachi, Yves Lepelletier, Danielle Canioni, Thomas A. Waldmann, Olivier Hermine, and Christophe Nicot
Blood 2006; 108: 1021-1029.
[Abstract]
[Full text]
[PDF]
The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia
- Lars Palmqvist, Bob Argiropoulos, Nicolas Pineault, Carolina Abramovich, Laura M. Sly, Gerald Krystal, Adrian Wan, and R. Keith Humphries
Blood 2006; 108: 1030-1036.
[Abstract]
[Full text]
[PDF]
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes
- Qian Zhang, Hong Y. Wang, Anders Woetmann, Puthiyaveettil N. Raghunath, Niels Odum, and Mariusz A. Wasik
Blood 2006; 108: 1058-1064.
[Abstract]
[Full text]
[PDF]
Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells
- Marion Gabillot-Carré, Yves Lepelletier, Martine Humbert, Paulo de Sepuvelda, Nadine Ben Hamouda, Jean Pierre Zappulla, Roland Liblau, Antoine Ribadeau-Dumas, François Machavoine, Sébastien Letard, Cédric Baude, Aurélie Hermant, Ying Yang, Jacques Vargaftig, Christine Bodemer, Emmanuel Morelon, Olivier Lortholary, Christian Recher, Guy Laurent, Michel Dy, Michel Arock, Patrice Dubreuil, and Olivier Hermine
Blood 2006; 108: 1065-1072.
[Abstract]
[Full text]
[PDF]
Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation
- Aline Mamo, Jana Krosl, Evert Kroon, Janet Bijl, Alexander Thompson, Nadine Mayotte, Simon Girard, Richard Bisaillon, Nathalie Beslu, Mark Featherstone, and Guy Sauvageau
Blood 2006; 108: 622-629.
[Abstract]
[Full text]
[PDF]
Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia
- Matthew F. Rudd, Gabrielle S. Sellick, Emily L. Webb, Daniel Catovsky, and Richard S. Houlston
Blood 2006; 108: 638-644.
[Abstract]
[Full text]
[PDF]
Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl–expressing human leukemia cells
- Warren Fiskus, Michael Pranpat, Purva Bali, Maria Balasis, Sandhya Kumaraswamy, Sandhya Boyapalle, Kathy Rocha, Jie Wu, Francis Giles, Paul W. Manley, Peter Atadja, and Kapil Bhalla
Blood 2006; 108: 645-652.
[Abstract]
[Full text]
[PDF]
MYC levels govern hematopoietic tumor type and latency in transgenic mice
- Darrin P. Smith, Mary L. Bath, Donald Metcalf, Alan W. Harris, and Suzanne Cory
Blood 2006; 108: 653-661.
[Abstract]
[Full text]
[PDF]
|
|
